Glofitamab in Chinese Patients With R/R DLBCL

Clinical trial NCT06481826 · RECRUITING

Trial details

NCT number: NCT06481826
Sponsor: Peking Union Medical College Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

DLBCL - Diffuse Large B Cell Lymphoma

Start date: 2024-01-01
Primary completion: 2027-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.